T2 Biosystems (TTOO) Reports Q4 Revenues Below Estimates; Provides Q1 & FY19 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Canaccord Defends T2 Biosystems (TTOO), Says Refuting the Short Story, Buy on Weakness
March 5, 2019 1:36 PM ESTCanaccord analyst Mark Massaro is defending T2 Biosystems (NASDAQ: TTOO) by saying buy on weakness. Analyst comments: "Shares of T2 Biosystems are down 15% on a short report that appears on Seeking Alpha. As we previewed this morning, T2 is set to... More
White Diamond Research negatived on T2 Biosystems (TTOO), sets $1.50 price target
March 5, 2019 10:03 AM ESTWhite Diamond Research negatived on T2 Biosystems (NASDAQ: TTOO), sets $1.50 price target (LINK)
